Prothena Corporation plc (PRTA) financial statements (2023 and earlier)

Company profile

Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
DUBLIN 2, D02 VK60
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments579295376428418387371
Cash and cash equivalents579295376428418387371
Restricted cash and investments 1     
Receivables 000001
Other current assets  3    
Other undisclosed current assets63 4846
Total current assets:585299378431426391377
Noncurrent Assets
Operating lease, right-of-use asset121823
Property, plant and equipment2345355564
Restricted cash and investments113 44 
Deferred income tax assets712 
Other noncurrent assets2011321
Other undisclosed noncurrent assets  1014863
Total noncurrent assets:2534416770698
TOTAL ASSETS:609333419499496460385
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities441214135
Accounts payable441114135
Taxes payable 00000 
Deferred revenue8  
Debt  5    
Restructuring reserve   0   
Other liabilities10766995
Other undisclosed current liabilities121567141913
Total current liabilities:33261815374122
Noncurrent Liabilities
Long-term debt and lease obligation61218    
Operating lease, liability61218
Liabilities, other than long-term debt1031111111022
Deferred revenue and credits022
Accounts payable and accrued liabilities     00
Deferred revenue103110110
Deferred rent credit   0
Other liabilities1111  0
Other undisclosed noncurrent liabilities   1605251 
Total noncurrent liabilities:11012312916152532
Total liabilities:143149146176899525
Stockholders' equity
Stockholders' equity attributable to parent466184273323407365361
Common stock0000000
Additional paid in capital1,182967944921849654489
Accumulated deficit(716)(783)(672)(598)(442)(289)(129)
Total stockholders' equity:466184273323407365361
TOTAL LIABILITIES AND EQUITY:609333419499496460385

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2013112812
Sublease income333
Gross profit:2013112812
Operating expenses(129)(114)(87)(160)(183)(161)(82)
Other undisclosed operating loss (2)     
Operating income (loss):72(113)(86)(159)(155)(160)(80)
Nonoperating income (expense)(0)183(2)10
Investment income, nonoperating      0
Other nonoperating income (expense)(0)(0)00(2)0(0)
Income (loss) from continuing operations before income taxes:72(111)(77)(156)(158)(159)(80)
Income tax expense (benefit)(5)0(0)04(1)(1)
Net income (loss) available to common stockholders, diluted:67(111)(78)(156)(153)(160)(81)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):67(111)(78)(156)(153)(160)(81)
Comprehensive income (loss), net of tax, attributable to parent:67(111)(78)(156)(153)(160)(81)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: